GP
CVS icon

Geneva Partners’s CVS Health CVS Stock Holding History

Geneva Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43,985
Closed -$4.45M – 61
2022
Q1 		$4.45M Sell
43,985
-990
-2% -$104K 2.75% 15
2021
Q4 		$4.64M Buy
+44,975
New +$4.16M 2.2% 17
2019
Q1 		– Sell
-49,712
Closed -$3.26M – 66
2018
Q4 		$3.26M Buy
+49,712
New +$3.71M 3.76% 9

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geneva Partners's CVS Position: Q2 2022 in Review

Geneva Partners sold out of CVS Health (CVS) in Q2 2022, closing a stake of 43,985 shares — an estimated $4.45M sold.

Geneva Partners first reported a position in CVS in Q4 2018 and held it in 3 quarters. The position peaked at $4.64M in Q4 2021. 2,308 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Geneva Partners reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
  • Geneva Partners sold 43,985 CVS Health shares in Q2 2022, an estimated $4.45M.
  • Geneva Partners first reported a position in CVS Health in Q4 2018 and held it in 3 quarters.
  • Geneva Partners's CVS Health position peaked at $4.64M in Q4 2021.
  • 2,308 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Geneva Partners's 13F filing for Q2 2022, filed 25 Jul 2022.